New York appears poised to become the latest state to adopt a drug take-back law, a slow-but-steady notion moving across the country as local governments grapple with budget constraints caused by unwanted or unused medicines and the opioid crisis. And the financial burden would, once again, fall on the pharmaceutical industry.

The New York state legislature last week unanimously passed a bill that would require drug makers to underwrite the cost of collecting and disposing of medicines. The measure must now be sent to New York Gov. Andrew Cuomo. We asked his office for comment and will pass along any reply. Last year, Cuomo vetoed a bill that would have required pharmacy chains — not drug makers — to largely pay for a statewide program.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Being a retired from the medical field for over 20 years even as a senior, I’m interested in the information the report will give me. I’m 81 and want t keep my brain up and running.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy